ALPN

OrbiMed’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,680,496	Closed	-$106M	–	120
2024 Q1	$106M	Buy	2,680,496 +145,251	+6%	+$5.76M	1.95%	12
2023 Q4	$48.3M	Sell	2,535,245 -1,546,347	-38%	-$29.5M	0.97%	38
2023 Q3	$46.7M	Hold	4,081,592	–	–	0.99%	38
2023 Q2	$42M	Hold	4,081,592	–	–	0.76%	47
2023 Q1	$31.5M	Hold	4,081,592	–	–	0.62%	54
2022 Q4	$30M	Hold	4,081,592	–	–	0.57%	58
2022 Q3	$29.4K	Hold	4,081,592	–	–	0.55%	60
2022 Q2	$34.7K	Hold	4,081,592	–	–	0.63%	49
2022 Q1	$36.6M	Hold	4,081,592	–	–	0.59%	48
2021 Q4	$56.5M	Hold	4,081,592	–	–	0.73%	45
2021 Q3	$43.6M	Buy	4,081,592 +1,010,637	+33%	+$10.8M	0.48%	59
2021 Q2	$27.6M	Hold	3,070,955	–	–	0.28%	86
2021 Q1	$32.6M	Hold	3,070,955	–	–	0.3%	78
2020 Q4	$38.7M	Sell	3,070,955 -600,000	-16%	-$7.56M	0.34%	71
2020 Q3	$32.3M	Hold	3,670,955	–	–	0.41%	66
2020 Q2	$35.6M	Hold	3,670,955	–	–	0.5%	58
2020 Q1	$10.6M	Hold	3,670,955	–	–	0.18%	82
2019 Q4	$14.1M	Hold	3,670,955	–	–	0.2%	73
2019 Q3	$14.5M	Hold	3,670,955	–	–	0.28%	72
2019 Q2	$15.5M	Hold	3,670,955	–	–	0.24%	76
2019 Q1	$25.2M	Buy	3,670,955 +372,439	+11%	+$2.55M	0.39%	63
2018 Q4	$12.1M	Hold	3,298,516	–	–	0.22%	80
2018 Q3	$20.9M	Hold	3,298,516	–	–	0.25%	87
2018 Q2	$25M	Hold	3,298,516	–	–	0.3%	74
2018 Q1	$26.4M	Hold	3,298,516	–	–	0.33%	71
2017 Q4	$36.9M	Hold	3,298,516	–	–	0.47%	62
2017 Q3	$38.3M	Buy	+3,298,516	New	+$38.3M	0.37%	73
2016 Q4	–	Sell	-59,000	Closed	-$480K	–	137
2016 Q3	$480K	Buy	+59,000	New	+$480K	0.01%	132